Order Article Reprints

Wu Y, Zheng S, Zhang Z, Chen G, Chen X, Zheng T, Guo X, Chen H, Wang M, Xie X, et al. Hepatic Arterial Infusion Chemotherapy with Oxaliplatin Plus Raltitrexed as an Alternative Option in Advanced Hepatocellular Carcinoma Patients with Failure of, or Unsuitability for, Transarterial Chemoembolization. Medicina. 2022; 58(10):1343. https://doi.org/10.3390/medicina58101343

Wu, Yanfang, Susu Zheng, Zhenzhen Zhang, Guobin Chen, Xiaochun Chen, Tanghui Zheng, Xinkun Guo, Hong Chen, Meixia Wang, Xiaoying Xie, and et al. 2022. "Hepatic Arterial Infusion Chemotherapy with Oxaliplatin Plus Raltitrexed as an Alternative Option in Advanced Hepatocellular Carcinoma Patients with Failure of, or Unsuitability for, Transarterial Chemoembolization" Medicina 58, no. 10: 1343. https://doi.org/10.3390/medicina58101343

Wu, Y., Zheng, S., Zhang, Z., Chen, G., Chen, X., Zheng, T., Guo, X., Chen, H., Wang, M., Xie, X., & Zhang, B. (2022). Hepatic Arterial Infusion Chemotherapy with Oxaliplatin Plus Raltitrexed as an Alternative Option in Advanced Hepatocellular Carcinoma Patients with Failure of, or Unsuitability for, Transarterial Chemoembolization. Medicina, 58(10), 1343. https://doi.org/10.3390/medicina58101343